RASAGILINE
- Product NDC
- 13668-446
- 11-digit product format
- 136680446
- Labeler code
- 13668
- Product ID
- 13668-446_fa1b2a7e-f459-4432-97f2-23d2c07c2dac
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- RASAGILINE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Torrent Pharmaceuticals Limited
- Application
- ANDA210150
- Marketing category
- ANDA
- Marketing start
- 2025-11-15
- Substance
- RASAGILINE MESYLATE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Monoamine Oxidase Inhibitor [EPC], Monoamine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- RASAGILINE
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RASAGILINE MESYLATE | 1 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | LH8C2JI290 |
| Rxcui | 608328, 636664 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 13668-446-05 | RASAGILINE | 500 in 1 CONTAINER | TABLET | 500 | | 6 |
| 13668-446-30 | RASAGILINE | 30 in 1 CONTAINER | TABLET | 30 | | 6 |
| 13668-446-90 | RASAGILINE | 90 in 1 CONTAINER | TABLET | 90 | | 6 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 13668-446-05 | 13668044605 | 500 TABLET in 1 CONTAINER (13668-446-05) | 500 tablet | 2025-11-15 | No | No | Historical |
| 13668-446-30 | 13668044630 | 30 TABLET in 1 CONTAINER (13668-446-30) | 30 tablet | 2025-11-15 | No | No | Historical |
| 13668-446-90 | 13668044690 | 90 TABLET in 1 CONTAINER (13668-446-90) | 90 tablet | 2025-11-15 | No | No | Historical |